Production of prostaglandins (PGs) and expression of their receptors have been demonstrated in bovine corpus luteum (CL). The aim of the present study was to determine whether PGE2 and PGF2alpha have roles in bovine luteal steroidogenic cell (LSC) apoptosis. Cultured bovine LSCs obtained at the midluteal stage (Days 8-12 of the cycle) were treated for 24 h with PGE2 (0.001-1 lM) and PGF2alpha (0.001-1 lM). Prostaglandin E2 (1 lM) and PGF2alpha (1 lM) significantly stimulated progesterone (P4) production and reduced the levels of cell death in the cells cultured with or without tumor necrosis factor alpha (TNF)/interferon gamma (IFNG), in the presence and absence of FAS ligand (P , 0.05). Furthermore, DNA fragmentation induced by TNF/IFNG was observed to be suppressed by PGE2 and PGF2alpha. Prostaglandin E2 and PGF2alpha also attenuated mRNA expression of caspase 3 and caspase 8, as well as caspase 3 activity (P , 0.05) in TNF/IFNGtreated cells. FAS mRNA and protein expression were decreased only by PGF2alpha (P , 0.05). A specific P4 receptor antagonist (onapristone) attenuated the apoptosis-inhibitory effects of PGE2 and PGF2alpha in the absence of TNF/IFNG (P , 0.05). A PG synthesis inhibitor (indomethacin) reduced cell viability in PGE2-and PGF2alpha-treated cells (P , 0.05). A specific inhibitor of cyclooxygenase (PTGS), PTGS2 (NS-398), also reduced cell viability, whereas an inhibitor of PTGS1 (FR122047) did not affect it. The overall results suggest that PGE2 and PGF2alpha locally play luteoprotective roles in bovine CL by suppressing apoptosis of LSCs. apoptosis, corpus luteum, corpus luteum function, progesterone, prostaglandins
INTRODUCTION
Luteal regression is characterized by a reduction in progesterone (P4) production (functional luteolysis) and tissue degeneration by apoptosis (structural luteolysis) [1] [2] [3] . Although prostaglandin F2a (PGF2a) administration to cows in the luteal phase decreases P4 production and then induces luteal cell death (apoptosis) in cattle [1] [2] [3] , PGF2a has been demonstrated to increase P4 production in cultured bovine luteal steroidogenic cells (LSCs) [4] [5] [6] . The reason for the opposite actions of PGF2a on LSCs between in vivo and in vitro is unclear. In addition, it is unclear whether PGF2a is involved in the regulation of apoptosis in LSCs. Prostaglandin E2 is known to be a luteotropic factor, since PGE2 stimulates P4 production by bovine LSCs in vitro [7, 8] . However, the role of PGE2 in the apoptosis of bovine LSCs has not been fully understood.
Apoptosis is mediated by death receptors, such as FAS (CD95) [9, 10] , and by many intracellular regulators, such as BCL2 family proteins [10] [11] [12] [13] and caspases [10, 13, 14] . FAS is a member of the tumor necrosis factor (TNF) receptor superfamily that is activated by binding to FAS ligand, leading to receptor aggregation and apoptotic signal transmission [9, 10] . When FAS is activated, two distinct intracellular apoptotic pathways can be executed, depending on the level of released active caspase 8 (CASP8) [9] . High levels of CASP8 directly initiate cleavage of downstream caspases, such as CASP3, thereby initiating the execution phase of apoptosis [9] . On the other hand, low levels of CASP8 require an amplification loop via mitochondria involving cleavage of BID, a proapoptotic member of the BCL2 family, in order to induce apoptosis [9] . BCL2 family proteins modulate the release of apoptogenic factors, such as cytochrome c, apoptosis-inducing factor, and Smac/Diablo, from mitochondria into the cytosol [13] . Release of such factors is believed to be one of the most important determinants of whether apoptosis proceeds [13] . Among the BCL2 family proteins, BCL2 is known to protect cells from apoptosis, whereas BAX accelerates cell death [10] [11] [12] [13] 15] . In cattle, FAS [16, 17] , BAX [18] , and caspases [19] have been shown to contribute to luteal cell death in vitro and in vivo [20] . However, the effects of PGE2 and PGF2a on proapoptosis and antiapoptosis genes in bovine LSCs are not known.
In the present study, we investigated the possible roles of PGE2 and PGF2a in bovine LSC apoptosis using a cytokineinduced apoptosis system, which we established in cultured bovine LSCs obtained from midstage corpus luteum (CL) [17] . In these studies, we determined the effects of PGE2 and PGF2a on cell viability, mRNA expression of FAS, BCL2, BAX, CASP8, and CASP3, as well as FAS protein expression and CASP3 activity. Since PGE2 [7, 8] and PGF2a [4] [5] [6] have been reported to stimulate P4 production by bovine LSCs, and P4 suppresses LSC apoptosis in bovine CL [19, 21] , we also examined whether P4 mediates the action of PGs by using a specific P4 receptor antagonist, onapristone (OP). Moreover, the effects of PG synthesis inhibitors (indomethacin, a nonspecific cyclooxygenase [PTGS] inhibitor; FR122047, a PTGS1-specific inhibitor; and NS-398, a PTGS2-specific inhibitor) on cell viability was also tested to check the role of endogenous PGs in LSC death.
MATERIALS AND METHODS

Collection of CL
Ovaries with CL from Holstein cows were collected at a local abattoir within 10-20 min after exsanguinations. Luteal stages were classified as early, developing, mid, late, or regressed by macroscopic observation of the ovary and uterus [22] . For cell culture experiments, the ovaries with mid-CL were submerged in ice-cold physiological saline and transported to the laboratory.
Cell Isolation
Luteal steroidogenic cells were obtained as described previously [23] . Briefly, mid-CL tissue from three cows was enzymatically dissociated, and the resulting cell suspensions were centrifuged (5 min at 50 3 g) three times to separate the LSCs (pellet) from endothelial cells and other types of luteal nonsteroidogenic cells (supernatant). The dissociated LSCs were suspended in a culture medium, Dulbecco modified Eagle medium, and Ham F-12 medium (1:1 [v/v]; no. D8900; Sigma-Aldrich Inc., St. Louis, MO) containing 5% calf serum (no. 16170-078; Life Technologies Inc., Grand Island, NY) and 20 lg/ ml gentamicin (no. 15750-060; Life Technologies). Cell viability was greater than 90%, as assessed by trypan blue exclusion. The cells in the cell suspension after centrifugation consisted of about 70% small LSCs, 20% large LSCs, 10% endothelial cells or fibrocytes, and no erythrocytes.
Cell Culture
The dispersed LSCs were seeded at 2.0 3 10 4 viable cells in 0.1 ml, in 96-well cluster dishes (no. 3860-096; Iwaki; Asahi Techno Glass, Chiba, Japan) for experiments 1, 5, 6, and 7, or at 4.0 3 10 5 viable cells in 2 ml in six-well cluster dishes (no. 657160; Greiner Bio-One, Frickenhausen, Germany) for experiment 2 (with glass slides), or at 2.0 3 10 5 viable cells in 1 ml in 24-well cluster dishes (no. 662160; Greiner Bio-One) for experiment 3, or at 4.0 3 10 6 viable cells in 20 ml in an 80-cm 2 culture flask (no. 658175; Greiner Bio-One) for experiment 4, and were cultured in a humidified atmosphere of 5% CO 2 in air at 388C in an N 2 -O 2 -CO 2 -regulated incubator (no. BNP-110; ESPEC CORP.). After 12 h of culture, the medium was replaced with fresh medium containing 0.1% BSA, 5 ng/ml sodium selenite, and 5 lg/ml transferrin, and the following experiments were carried out.
Experiment 1: Cell Viability and P4 Production
Luteal steroidogenic cells were cultured with 0.001-1 lM PGE2 (no. P0409; Sigma) or 0.001-1 lM PGF2a (no. P7652; Sigma) with or without 2.9 nM recombinant human tumor necrosis factor a (TNF; Dainippon Pharmaceutical, Osaka, Japan) and 2.5 nM recombinant bovine interferon c (IFNG; kindly donated by Dr. S. Inumaru, NIAH, Ibaraki, Japan) in the presence or absence of 2.9 nM soluble recombinant human FAS ligand (FASLG; no. 01-193; Upstate Biotechnology, Lake Placid, NY) for 24 h. The doses for treatments were selected based on previous reports [4, 8, 17, 24] . The viability of the cells was determined using a Dojindo Cell Counting Kit including WST-1 (No. 345-06463; Dojindo, Kumamoto, Japan) as described previously [17] . Progesterone concentrations in the media of LSCs cultured with 1 lM PGE2 or 1 lM PGF2a were measured by enzyme immunoassay.
Experiment 2: DNA Fragmentation
Luteal steroidogenic cells were cultured with 1 lM PGE2 or 1 lM PGF2a with or without 2.9 nM TNF and 2.5 nM IFNG for 24 h. After the culture, the cells were washed twice with 1 ml PBS (no. 05193; Seikagaku Corp., Tokyo, Japan). The cells were fixed for 1 h at room temperature in PBS containing 4% paraformaldehyde, followed by two washes in PBS before permeabilization with 0.5% Triton X-100 (Bio-Rad, Hercules, CA) in PBS for 20 min. Cells were then briefly washed twice in PBS. The cells were incubated in 30 ll fluorescein-conjugated dUTP and terminal deoxynucleotidyl transferase (TUNEL reagents; no. 8845; MBL, Nagoya, Japan) for 1 h at 378C in a dark, moist chamber. After the TUNEL reaction, the cells were washed twice in PBS and once in PBS containing 0.0002% propidium iodide (PI; no. P4170; Sigma). The cells were then washed three times in PBS and stored in the dark at 48C. The cells were observed under fluorescent illumination using a 470-nm excitation filter and a 515-nm absorption filter for fluorescein isothiocyanate (FITC) and a 545-nm excitation filter and a 610-nm absorption filter for PI. 
Experiment 3: FAS, BCL2, BAX, CASP8, and CASP3 mRNA Expression
Luteal steroidogenic cells were treated as for experiment 2. After the culture, total RNA was extracted for determination of FAS, BCL2, BAX, CASP8, and CASP3 mRNA expression.
Experiment 4: FAS Protein Expression
Luteal steroidogenic cells were treated as for experiment 2. The cultured cells were scraped and placed in ice-cold homogenization buffer (25 mM TrisHCl, 300 mM sucrose, 2 mM EDTA, Complete [protease inhibitor cocktail; no. 1697498; Roche], pH 7.4), then frozen in liquid nitrogen, and then stored at À808C until FAS protein analysis by Western blotting.
Experiment 5: CASP3 Activity
Luteal steroidogenic cells were treated as for experiment 2. After the culture, the cells were washed three times in PBS, and CASP3 activity was measured using a commercially available CASP3 assay kit (EnzoLyte Homogenous AMC Caspase-3 Assay Kit; no. 71118; Anaspec, San Jose, CA).
Experiment 6: Effect of a P4 Receptor Antagonist on Cell Viability
Luteal steroidogenic cells were cultured with 1 lM PGE2 or 1 lM PGF2a, with or without 2.9 nM TNF and 2.5 nM IFNG, in the presence or absence of 100 lM OP (a specific P4 receptor antagonist; no. ZK98299; Schering AG, Berlin, Germany) for 24 h. The dose for OP was selected based on a previous report [19] . The cell viability was determined by WST-1 assay.
Experiment 7: Effect of PG Synthesis Inhibitors on Cell Viability
Luteal steroidogenic cells were cultured with 1 lM PGE2 or 1 lM PGF2a, with or without 2.9 nM TNF and 2.5 nM IFNG, in the presence or absence of 100 lM indomethacin (a nonspecific PTGS inhibitor; no. I7378; Sigma), 0.1 lM FR122047 (a PTGS1-specific inhibitor; no. 10039; Cayman, Ann Arbor, MI), or 0.01 lM NS-398 (a PTGS2-specific inhibitor; no. 70590; Cayman) for 24 h. The dose for indomethacin was selected based on previous reports [25] . The doses for FR122047 and NS-398 were determined by dose-response test. The cell viability was determined by WST-1 assay.
P4 Determination
Concentrations of P4 were determined directly from the cell culture media with an enzyme immunoassay as described previously [4] . The standard curve ranged from 0.391 to 100 ng/ml, and the effective dose of the assay for 50% inhibition was 4.5 ng/ml. The intraassay and interassay coefficients of variation were 8.3% and 11.6%, respectively.
WST-1 Assay
, is a yellow tetrazolium salt that is reduced to formazan by live cells containing active mitochondria. For the viability assay, the culture medium was replaced with 100 ll D/F medium without Phenol red, and 10 ll assay solution (0.3% WST-1, 0.2 mM 1-methoxy-5-methylphenazinium methylsulfate [1-methoxy PMS] in PBS, pH 7.4) was added to each well. The cells were then incubated for 4 h at 378C. The absorbance (A) was read at 450 nm using a microplate reader (model 450; Bio-Rad). Cell viability (%) was calculated as cell viability (%) ¼ 100 3 (A test /A control ), where A control is the mean A of nontreated wells, and A test is the mean A of all experimental wells.
RNA Isolation and cDNA Synthesis
Total RNA was prepared from cultured LSCs using TRIZOL Reagent according to the manufacturer's directions (no. 15596-026; Invitrogen, Carlsbad, CA). Total RNA (1 lg) was reverse transcribed using a ThermoScript RT-PCR System (no. 11146-016; Invitrogen).
Quantitative PCR (Real-Time PCR)
Gene expression was measured by real-time PCR using the MyiQ (Bio-Rad) and the iQ SYBR Green PCR supermix (no. 170-8880; Bio-Rad), starting with 2
ROLES OF PROSTAGLANDINS IN LUTEAL CELL DEATH
ng reverse transcribed total RNA as described previously [26] . Standard curves of sample cDNA were generated using serial dilutions (1:2 to 1:1000). b-Actin (ACTB) expression was used as an internal control. Twenty-base pair primers with 50%-60% guanine-cytosine contents were synthesized (Table 1) . Polymerase chain reaction conditions were: 958C for 3 min, followed by 45 cycles of 948C for 15 sec, 558C for 20 sec, and 728C for 15 sec. Use of the iQ SYBR Green supermix at elevated temperatures resulted in reliable and sensitive quantification of the PCR products with high linearity (Pearson correlation coefficient, r . 0.99).
FAS Protein Analysis
FAS in the cultured bovine LSCs was detected by Western blotting analysis. The cultured cells (Experiment 4) were lysed in 200 ll lysis buffer (20 mM Tris-HCl, 150 mM NaCl, 1% Triton X-100, 10% glycerol [no. G7757; Sigma] Complete, pH 7.4). Protein concentrations in the lysates were determined by the method of Osnes et al. [27] , using BSA as a standard. The proteins were then solubilized in SDS gel-loading buffer (50 mM Tris-HCl, 2% SDS [no. 31607-94; Nacalai Tesque Inc., Kyoto, Japan], 10% glycerol, 1% b-mercaptoethanol [no. 137-06862; Wako Pure Chemical Industries Ltd., Osaka, Japan], pH 6.8), and heated at 958C for 10 min. Samples (50 lg protein) were subjected to electrophoresis on a 10% SDS-PAGE for 80 min at 200 V.
The separated proteins were electrophoretically transblotted to a 0.2-lm nitrocellulose membrane (no. LC2000; Invitrogen) at 100 V for 3 h in transfer buffer (25 mM Tris-HCl, 192 mM glycine, 20% methanol, pH 8.3). The membrane was washed in TBS-T (0.1% Tween 20 in TBS [25 mM Tris-HCl, 137 mM NaCl, pH 7.5]) and incubated in blocking buffer (4% nonfat dry milk in TBS-T) overnight at 48C. After blocking incubation, the membrane was cut into two pieces: one piece was used for detecting FAS protein (60.7 kDa), and the other piece was used for ACTB (internal standard, 42 kDa). The membranes were then incubated separately with a primary antibody specific to each protein (FAS antibody [1:1000 in TBS-T; no. SC715; Santa Cruz Biotechnology] and ACTB antibody [1:4000 in TBS-T; no. A2228; Sigma]) for 1 h at room temperature, washed three times for 10 min in TBS-T at room temperature, incubated with secondary antibody (anti-mouse immunoglobulin, horseradish peroxidase-linked whole antibody produced in sheep; 1:20 000 in TBS-T; no. NA931; Amersham Biosciences Corp., Piscataway, NJ) for 1.5 h, and washed three times in TBS for 10 min at room temperature. The signal was detected by ECL Western Blotting Detection System (no. RPN2109; Amersham Biosciences). The intensity of the immunological reaction in the cells was estimated by measuring the optical density in the defined area by computerized densitometry using NIH Image (National Institutes of Health).
FIG. 1. Effects of PGE2 (
A) and PGF2a (B) on cell viability. Luteal steroidogenic cells were treated
Statistical Analysis
All experimental data are shown as the mean 6 SEM. The data of cell viability and CASP3 activity are shown as a percentage of control. The statistical significance of differences was assessed by analysis of variance (ANOVA) followed by a Bonferroni protected least-significant difference procedure (PLSD) as a multiple comparison test.
RESULTS
Experiment 1: Cell Viability and P4 Production
Treatment with TNF and IFNG in the presence and absence of FASLG reduced cell viability (P , 0.05; Fig. 1B) . A total of 1 lM PGE2 and 1 lM PGF2a significantly increased cell viability in the presence and absence of TNF, IFNG, and FASLG (P , 0.05; Fig. 1, A and B) . Prostaglandin E2 and PGF2a stimulated P4 production by LSCs (P , 0.05; Fig. 2 ).
Experiment 2: DNA Fragmentation
Staining with PI showed that the nuclei of the cells treated with TNF and IFNG for 24 h were condensed compared with control (Fig. 3A, left panels) , and TUNEL staining showed that DNA fragmentation occurred in the same treatment (Fig. 3A , right panels). Prostaglandin E2 and PGF2a attenuated the DNA fragmentation increased by TNF and IFNG (P , 0.05; Fig. 3B ).
Experiment 3: FAS, BCL2, BAX, CASP8, and CASP3 mRNA Expression
A real-time PCR analysis showed that PGF2a significantly attenuated FAS mRNA expression induced by TNF and IFNG (P , 0.05; Fig. 4A ), whereas PGE2 did not affect it.
Neither PGE2 nor PGF2a affected BCL2 and BAX mRNA expression or the BCL2:BAX mRNA ratio in the cells.
Prostaglandin E2 and PGF2a significantly decreased both CASP8 (Fig. 4B) and CASP3 (Fig. 4C) mRNA expression induced by TNF and IFNG (P , 0.05).
Experiment 4: FAS Protein Expression
In all treatments, a single FAS-specific band was detected by Western blotting (Fig. 5A) . Intensities of the bands, after normalization to ACTB-specific bands, revealed that PGF2a significantly decreased FAS protein expression induced by TNF and IFNG (P , 0.05; Fig. 5B ), whereas PGE2 did not affect it.
Experiment 5: CASP3 Activity
Prostaglandin E2 and PGF2a significantly attenuated CASP3 activity induced by TNF and IFNG (P , 0.05; Fig. 6 ).
Experiment 6: Effect of a P4 Receptor Antagonist on Cell Viability
A specific P4 receptor antagonist (OP) reduced cell viability in PGE2-or PGF2a-treated cells in the absence of TNF and IFNG (P , 0.05; Fig. 7) , whereas it did not affect cell viability in the presence of TNF and IFNG. 
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Experiment 7: Effect of PG Synthesis Inhibitors on Cell Viability
Indomethacin (a nonspecific PTGS inhibitor) reduced cell viability in PGE2-or PGF2a-treated cells in the presence or absence of TNF and IFNG (P , 0.05; Fig. 8A ), whereas it did not affect the cell viability in non-PG-treated cells. A PTGS1-specific inhibitor (FR122047) did not alter cell viability in any treatment. A PTGS2-specific inhibitor (NS-398) reduced cell viability both in PG-treated cells and non-PG-treated cells in the absence of TNF and IFNG, whereas it reduced cell viability only in PG-treated cells in the presence of TNF and IFNG (P , 0.05; Fig. 8C ).
DISCUSSION
Our results show that PGE2 and PGF2a suppressed apoptosis of bovine LSCs. Although PGE2 and PGF2a are produced by bovine LSCs [28] [29] [30] , and their receptors are present on the cells [31] , the roles of PGs in the regulation of LSC apoptosis have not been fully understood. In the present study, PGE2 and PGF2a significantly suppressed cell death, CASP3 and CASP8 mRNA expression, and CASP3 activity induced by TNF and IFNG. Characteristic features of apoptosis, such as shrunken nuclei and DNA fragmentation, were also suppressed by these PGs. Furthermore, a PG synthesis inhibitor, indomethacin, decreased cell viability. The above findings strongly suggest that endogenous PGE2 and PGF2a locally act as antiapoptotic factors in LSCs for maintenance of CL function. The concentrations of PGs used in the present in vitro study were much higher than previously reported values in the jugular venous blood (PGE2, 19.0-113.1 pg/ml; PGF2a, 2.1-6.0 pg/ml) [32] . This is because bovine LSCs produce large amounts of PGs [28] [29] [30] 33] , so that local PG concentrations in the CL microenvironment might be much higher than those in the blood plasma.
Both intramuscular PGF2a injection [34] and endogenous uterine PGF2a [35] induce luteolysis. Luteal PGF2a stimulated by injected or uterine PGF2a also seems to promote luteolysis in the cow [32] . On the other hand, treatment of PGF2a alone stimulated rather than decreased P4 production in cultured bovine LSCs in the present study. Therefore, it is still unclear how exogenous or endogenous PGF2a decreases P4 production in CL in the cow. The present results indicate that PGF2a has direct antiapoptotic action on bovine LSCs, and they suggest that PGF2a has luteoprotective or luteotropic roles in the CL. There is increasing evidence that other types of cells in the CL, that is, endothelial cells [5, [36] [37] [38] [39] [40] , immune cells [5] , and intercellular communication in CL [5, 40, 41] , are required to achieve functional and structural luteolysis. Liptak et al. [5] showed that PGF2a decreased P4 production of LSCs only when the LSCs were cultured with activated mononuclear cells, and they suggested that substances from activated mononuclear 6 . Effects of PGE2 and PGF2a on CASP3 activity. Luteal steroidogenic cells were treated with PGE2 (1 lM) or PGF2a (1 lM) with or without TNF (2.9 nM) and IFNG (2.5 nM) for 24 h. CASP3 activity was measured using a CASP3 assay kit (defined in Materials and Methods) according to the manufacturer. Different letters indicate significant differences (P , 0.05), as determined by ANOVA followed by a Bonferroni PLSD as a multiple comparison test. cells and/or contact between activated mononuclear cells and luteal cells are needed for PGF2a to decrease P4 production in bovine LSCs. In addition, ovarian blood flow has been shown to decrease during spontaneous and PGF2a-induced luteolysis in cows [42, 43] and in ewes [44, 45] , suggesting that luteolysis is correlated with a decrease in blood supply. Recently, we found that reduced oxygen tension decreased P4 synthesis [46] and induced apoptosis in bovine LSCs [47] . Together, these results suggest that a decrease of blood supply is required for spontaneous and PGF2a-induced luteolysis. Therefore, luteolysis induced by endogenous or exogenous PGF2a seems to occur only in the presence of the other cell types and cell-tocell contact, and under the influence of a decrease in blood supply. Our present study showed that PGs, including PGF2a, act as antiapoptotic factors in cultured bovine LSCs.
Since P4 has been demonstrated to suppress apoptosis of bovine LSCs [19, 21] , we hypothesized that PGE2 and PGF2a suppress apoptosis through stimulation of P4 production. In the present study and previous studies, both PGE2 [7, 8] and PGF2a [4] [5] [6] stimulated P4 production by LSCs. Furthermore, OP (a specific P4 receptor antagonist) reduced the cell viability in PGE2-or PGF2a-treated cells in the absence of TNF and IFNG. These findings confirm the above hypothesis. In the presence of TNF and IFNG, PGs showed several antiapoptotic effects: they increased cell viability, decreased FAS, CASP8, and CASP3 mRNA expression, and decreased FAS protein expression and CASP3 activity. However, OP did not affect the cell viability in the PG-treated cells in the presence of TNF and IFNG. Thus, PGE2 and PGF2a may suppress apoptosis by other pathways in the presence of TNF and IFNG. The reason for the difference in the effect of OP between absence and presence of TNF and IFNG is unclear. One possibility is that IFNG-inhibited P4 production [48] attenuated the antagonistic effect of OP on the antiapoptotic P4 effect on bovine LSCs.
In the present study, indomethacin did not decrease the cell viability in non-PG-treated cells, but it significantly reduced the increase of viability induced by PGE2 or PGF2a. These findings suggest that endogenous PGs induced by PG treatment increase the survival of LSCs. NS-398, a specific inhibitor of inducible isoform of PG synthetic enzyme (PTGS2) [49] , also reduced cell viability, whereas FR122047, an inhibitor of constitutively expressed isoform (PTGS1) [50] , did not decrease cell viability. Furthermore, because both treatments of either PGE2 or PGF2a alone increased cell viability in the present study, we suggest that endogenous PGE2 and PGF2a synthesized by PTGS2 suppress LSC apoptosis and act to maintain the bovine CL. However, since NS-398 has also been reported to have some other actions independent of PTGS2 inhibition [51] [52] [53] , it is possible that the dose of NS-398 used in the present study causes cell death independently of effects on PG production. Further studies are needed to clarify these points.
The FAS/FASLG system has been demonstrated to be involved in apoptosis in bovine LSCs, and cytokines such as TNF and IFNG strengthen this system by upregulating FAS mRNA expression [17] . In the present study, PGF2a reduced (1 lM) with or without TNF (2.9 nM) and IFNG (2.5 nM), in the presence or absence of 100 lM indomethacin, 0.1 lM FR122047, or 0.01 lM NS-398 for 24 h. Cell viability was determined by optical density at 450 nm in a WST-1 assay. All values are expressed as a percentage of cytotoxicity (defined in Materials and Methods) and represent mean 6 SEM of three separate experiments. Different letters indicate significant differences among all comparisons in each panel (P , 0.05). Significant differences were determined by ANOVA followed by a Bonferroni PLSD as a multiple comparison test. FIG. 7 . Effect of a P4 receptor antagonist (OP) on cell viability. Luteal steroidogenic cells were treated with PGE2 (1 lM) or PGF2a (1 lM) with or without TNF (2.9 nM) and IFNG (2.5 nM), in the presence or absence of 100 lM OP for 24 h. Cell viability was determined by optical density at 450 nm in a WST-1 assay. All values are expressed as a percentage of cytotoxicity (defined in Materials and Methods) and represent mean 6 SEM of three separate experiments. Different letters indicate significant differences among all comparisons in each panel (P , 0.05). Significant differences were determined by ANOVA followed by a Bonferroni PLSD as a multiple comparison test.
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FAS mRNA and protein expression as well as cell death induced by TNF and IFNG. These findings suggest that PGF2a suppresses FAS/FASLG-induced apoptosis by reducing FAS mRNA and protein expression in bovine LSCs.
We previously reported that cotreatment with TNF and IFNG in cultured bovine LSCs induces apoptotic cell death [17] . Tumor necrosis factor a [54, 55] and IFNG [48] are also known to stimulate luteal PG production. In the present study, PGs protected LSCs from apoptosis induced by TNF and IFNG. These findings suggest that TNF and IFNG promote LSC apoptosis, whereas they stimulate the production of PGs, which have antiapoptotic effects at high concentrations. Since the capacity of bovine LSCs to synthesize PGs is highest at the early luteal stage and decreases toward the regressed luteal stage [28, 29, 33, 55] , the early LSCs with high PG synthetic capacity may be protected from apoptosis. On the other hand, the regressing LSCs with low PG synthetic capacity may undergo apoptosis when they are exposed to cytokines produced by immune cells, which invade the CL at the late luteal stage [56] . Furthermore, in bovine luteal endothelial cells, TNF and IFNG stimulate nitric oxide (Acosta and Okuda, unpublished data) and endothelin 1 [38] , both of which contribute to luteolysis [36] [37] [38] [39] . Based on the above evidence, interactions among TNF, IFNG, and the other factors secreted by immune cells (i.e., interleukin 1 [33, 57] ) and luteal endothelial cells (i.e., nitric oxide [36, 37] , endothelin 1 [37] [38] [39] ) are necessary for structural luteolysis.
BCL2 family proteins, including BCL2 and BAX, are known to regulate the release of apoptogenic factors, such as cytochrome c, apoptosis-inducing factor, and Smac/Diablo, from mitochondria into the cytosol. Release of such factors is one of the critical determinants of whether apoptosis proceeds [13] . The BCL2:BAX expression ratio is thought to be a critical determinant of cell fate: a high ratio favors extended survival of cells, whereas a low ratio accelerates cell death [15, 18, 58, 59] . The BCL2:BAX mRNA expression ratio in bovine CL tissue also has been suggested to have some correlation with the regulation of luteolysis in cattle, because the ratio decreases only at the time of CL regression [59] . In the present study, however, neither PGE2 nor PGF2a affected the BCL2:BAX mRNA expression ratio in cultured bovine LSC. Thus, it is possible that PGs attenuate apoptosis without affecting the amplification loop via the mitochondria.
In conclusion, the overall results of the present study suggest that endogenous PGE2 and PGF2a suppress luteal steroidogenic cell apoptosis induced by TNF/IFNG and FAS/ FASLG, and that these PGs have possible luteotropic roles that contribute to the development or maintenance of bovine CL.
